NYSE - Delayed Quote USD

Encompass Health Corporation (EHC)

Compare
98.19 -0.47 (-0.48%)
At close: December 13 at 4:00:02 PM EST
98.45 +0.26 (+0.26%)
After hours: December 13 at 7:41:58 PM EST
Loading Chart for EHC
DELL
  • Previous Close 98.66
  • Open 98.40
  • Bid 98.42 x 900
  • Ask 99.71 x 900
  • Day's Range 98.11 - 99.39
  • 52 Week Range 65.39 - 104.55
  • Volume 523,320
  • Avg. Volume 654,296
  • Market Cap (intraday) 9.893B
  • Beta (5Y Monthly) 0.78
  • PE Ratio (TTM) 23.10
  • EPS (TTM) 4.25
  • Earnings Date Feb 5, 2025 - Feb 10, 2025
  • Forward Dividend & Yield 0.68 (0.69%)
  • Ex-Dividend Date Jan 2, 2025
  • 1y Target Est 115.67

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions. It offers services through the Medicare program to federal government, managed care plans and private insurers, state governments, and other patients. The company was formerly known as HealthSouth Corporation and changed its name to Encompass Health Corporation in January 2018. The company was incorporated in 1984 and is based in Birmingham, Alabama.

www.encompasshealth.com

27,481

Full Time Employees

December 31

Fiscal Year Ends

Recent News: EHC

View More

Performance Overview: EHC

Trailing total returns as of 12/13/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

EHC
47.97%
S&P 500
26.86%

1-Year Return

EHC
49.94%
S&P 500
30.31%

3-Year Return

EHC
100.96%
S&P 500
28.42%

5-Year Return

EHC
86.88%
S&P 500
90.97%

Compare To: EHC

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: EHC

View More

Valuation Measures

Annual
As of 12/13/2024
  • Market Cap

    9.89B

  • Enterprise Value

    12.54B

  • Trailing P/E

    23.10

  • Forward P/E

    20.53

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    1.92

  • Price/Book (mrq)

    5.05

  • Enterprise Value/Revenue

    2.41

  • Enterprise Value/EBITDA

    10.97

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    8.10%

  • Return on Assets (ttm)

    8.38%

  • Return on Equity (ttm)

    22.92%

  • Revenue (ttm)

    5.22B

  • Net Income Avi to Common (ttm)

    431.5M

  • Diluted EPS (ttm)

    4.25

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    147.8M

  • Total Debt/Equity (mrq)

    102.71%

  • Levered Free Cash Flow (ttm)

    103.55M

Research Analysis: EHC

View More

Company Insights: EHC

Research Reports: EHC

View More

People Also Watch